drugset / Trial / NCT00239265

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome

NCT00239265 ↗

Phase 3 Completed Astellas Pharma Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Tamuslosin is effective in the treatment of lower urinary tract syndrome with female patients.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamuslosin Unknown — —